News Conference News SCAI 2025 Benefits of TAVI Before Symptom Onset Not Hindered by Age: EARLY TAVR L.A. McKeown May 02, 2025
News Conference News SCAI 2025 More Patient-Prosthesis Mismatch With TAVI in Women, but 5-Year Survival Unaffected L.A. McKeown May 02, 2025
News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Conference News ACC 2025 EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes L.A. McKeown April 07, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News CRT 2025 STEMI Revascularization Times All Over the Map: GWTG Registry L.A. McKeown March 14, 2025
News Conference News CRT 2025 ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions L.A. McKeown March 14, 2025
News Conference News CRT 2025 Need for Rethink of Discharge Medications After LAA Closure? EMERGE L.A. McKeown March 12, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Daily News Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014 L.A. McKeown March 05, 2025
News Daily News PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent L.A. McKeown February 11, 2025
News Daily News As More Peripheral Interventions Go Radial, the AHA Offers Some Insights L.A. McKeown December 12, 2024
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024